EU Clinical Trial Information System (CTIS)

Brand Logo

Brand Logo Light

Explanation of how the number of participants for analysis was determined. Includes whether analysis was per protocol, intention to treat, or another method. Also provides relevant details such as imputation technique, as appropriate.

I searched for some studies on AstraZeneca Clinical Trials, and found these studies that may also be of interest to you.
Here is the link to my search results

Official Title

To determine the accuracy of SCreening for Occult REnal Disease (SCORED)
questionnaire for CKD risk among Asian Patients

To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients

CTIS Number

EudraCT Number

NCT ID

Patient Level Data

Therapeutic Area

Research Site

Perisai Husada

Nguyen Tri Phuong Hospital

A Real-World Multicentre
Prospective Study to Determine the Accuracy of the SCORED (SCreening for Occult
REnal Disease) Questionnaire for SCreening REnal Risk Early Against Nephropathy
in Adult Population in Asia

The primary objective is to evaluate the accuracy of SCORED tool in identifying individuals at risk for the development of CKD in the Asian population. The primary outcomes, sensitivity, and specificity will be summarised using percentage and 95% confidence intervals to be measured at Baseline up to 6months after enrollment

To determine the accuracy of SCreening for Occult REnal Disease (SCORED) questionnaire for CKD risk among Asian Patients - SCREEN

Official Title

Medical condition

Phase

Healthy volunteers

Study drug

Sex

Actual Enrollment

Study type

Age

Date

Study design

Verification:

Sponsors

Collaborators

Inclusion Criteria

Exclusion Criteria

Documents available

Trial Results Summaries

Contacts

Contact